---
title: Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors
nct_id: NCT01824745
overall_status: ACTIVE_NOT_RECRUITING
phase: NA
sponsor: City of Hope Medical Center
study_type: INTERVENTIONAL
primary_condition: Breast Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01824745.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01824745"
ct_last_update_post_date: 2026-03-13
last_seen_at: "2026-05-12T07:12:25.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors

**Official Title:** Survivorship Care Planning for At Risk Breast Cancer Survivors

**NCT ID:** [NCT01824745](https://clinicaltrials.gov/study/NCT01824745)

## Key Facts

- **Status:** ACTIVE_NOT_RECRUITING
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 100
- **Lead Sponsor:** City of Hope Medical Center
- **Collaborators:** National Cancer Institute (NCI)
- **Conditions:** Breast Cancer, Cancer Survivor
- **Start Date:** 2013-07-15
- **Completion Date:** 2026-06-15
- **CT.gov Last Update:** 2026-03-13

## Brief Summary

This randomized pilot clinical trial studies survivorship care planning in improving the quality of life in breast cancer survivors. Survivorship care planning may reduce stress and improve the well-being and quality of life of cancer survivors.

## Detailed Description

PRIMARY OBJECTIVES:

I. Test the effectiveness of the navigation intervention and survivorship care plan (SCP)-breast cancer survivors (BCS) template booklet on accessing and adhering to SCP-BCS guidelines compared to the control group receiving usual care and the SCP-BCS template booklet.

SECONDARY OBJECTIVES:

I. Develop a clinically and psychosocially responsive SCP-breast cancer survivors (SCP-BCS) template in English and English-Spanish adopted from American Society of Clinical Oncology (ASCO)-SCP.

II. Assess the acceptability, utility and format preference (electronic vs paper) of the SCP-BCS template.

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.

ARM II: Participants receive SCP-BCS template booklet and receive standard follow-up care.

After completion so study treatment, participants are followed up at 6 and 12 months.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* In early survivorship phase, defined as being post-surgery to ending of active treatment to 18 months post active treatment for stage 0-3 breast cancer (BCA)
* Reside in Southern California
* BCS treated at Kaiser, an health maintenance organization (HMO) provider, will be excluded since their SCP implementation project is underway
* BCS will not be excluded based on cancer treatments received or a history of diagnosis of mild depression, anxiety, and hypertension and diabetes
```

## Arms

- **Arm I (SCP-BCS template booklet and counseling)** (EXPERIMENTAL) — Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
- **Arm II (SCP-BCS template booklet)** (ACTIVE_COMPARATOR) — Participants receive SCP-BCS template booklet and receive standard follow-up care.

## Interventions

- **educational intervention** (OTHER) — Receive the SCP-BCS template booklet
- **counseling intervention** (OTHER) — Receive counseling sessions with a patient navigator
- **standard follow-up care** (PROCEDURE) — Receive standard follow-up care
- **quality-of-life assessment** (PROCEDURE) — Ancillary studies
- **questionnaire administration** (OTHER) — Ancillary studies

## Primary Outcomes

- **Proportion of BCS accessing a SCP from their oncology provider** _(time frame: At 6 months)_ — Fisher's exact test will be used to test the null hypothesis (at least 40% of trial participants will have access to SCP).

## Secondary Outcomes

- **Adherence to SCP guidelines** _(time frame: At 12 months)_
- **Proportion of BCS accessing a SCP from their oncology provider** _(time frame: At 12 months)_

## Locations (2)

- City of Hope Medical Center, Duarte, California, United States
- City of Hope Antelope Valley, Lancaster, California, United States

## Recent Field Changes (last 30 days)

- `results.hasResults` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `locations.city of hope medical center|duarte|california|united states` — added _(2026-05-12)_
- `locations.city of hope antelope valley|lancaster|california|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01824745.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01824745*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*